Diethylpropion vs. Phentermine

Are diethylpropion and phentermine the same drug?

No — they are two different molecules, but they belong to the same class and are used the same way. Both are sympathomimetic amines (chemically related to amphetamine) that suppress appetite, both are Schedule IV controlled substances, and both are FDA-approved only as a short-term aid to a reduced-calorie diet — not as a long-term treatment [1], [2].

The practical differences are how often they're dosed, how commonly they're prescribed, and small differences in how each is tolerated.

Short-term on the label — but used flexibly under supervision

This is the most important context for the comparison. Diethylpropion and phentermine date to the 1950s–60s, and their FDA labels cover only "a few weeks" of use — a limit set by the short trials of that era, not by evidence that longer use is unsafe.

Tellingly, the very same phentermine is FDA-approved for long-term use inside Qsymia (phentermine plus topiramate), once a manufacturer ran the longer studies.

In experienced hands these drugs are used flexibly — sometimes beyond a few weeks, or in combination with another agent — for selected patients under close supervision, as part of individualized care. They are older, inexpensive tools; whether one fits a short jump-start or a longer supervised plan is a clinical decision, not a fixed rule.

What is phentermine?

Phentermine is the most widely prescribed weight-loss drug in the United States — a sympathomimetic appetite suppressant (brands include Adipex-P and Lomaira) approved for short-term use in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition.

It is usually taken as 37.5 mg once daily before or shortly after breakfast (lower 15–30 mg doses and an 8 mg three-times-daily form also exist) [2].

What is diethylpropion?

Diethylpropion (formerly sold as Tenuate) is an older sympathomimetic appetite suppressant in the same short-term class. It comes as a 25 mg immediate-release tablet taken three times a day before meals, or a 75 mg controlled-release tablet taken once daily mid-morning [1].

It is prescribed far less often than phentermine today, but is sometimes chosen as an alternative — for example, when someone finds phentermine too stimulating.

How they work

Both work as stimulants that reduce appetite. As sympathomimetic amines, they prompt the release of norepinephrine (and related neurotransmitters) in the brain, which suppresses hunger [1], [2]. Because the mechanism is stimulant-based, the side effects and cautions are also stimulant-type — and quite similar between the two drugs.

This is very different from how GLP-1 medications or Contrave work, which is part of why this older class is limited to short-term use.

Effectiveness: is one stronger?

Both produce modest, short-term weight loss, and high-quality head-to-head trials directly comparing them are sparse and old.

In practice, phentermine is generally regarded as somewhat more potent and is the default choice, which is a large part of why it is prescribed far more often; diethylpropion is considered a roughly comparable but milder alternative [1], [2], [3].

With either drug, the weight lost is modest compared with newer long-term medications, and it tends to return once the short course ends — which is why they are positioned as a kick-start alongside diet and activity changes, not a stand-alone solution.

What to expect and monitoring

Think of these as a short-term jump-start, not a cure. Expect modest weight loss over a few weeks while appetite is suppressed; the medication only works as an adjunct to a reduced-calorie diet and more activity.

Because both raise heart rate and blood pressure, a clinician typically checks those before and during treatment, and the labels advise stopping the drug if it stops producing meaningful weight loss or if tolerance develops — the appetite-suppressing effect often fades within weeks [1], [2].

The diet and activity habits you build during the short course are what carry the result forward once it ends.

Dosing & administration

Phentermine is typically 37.5 mg once daily (taking it early avoids insomnia) [2]. Diethylpropion is 25 mg three times a day before meals, or a 75 mg controlled-release tablet once daily mid-morning [1]. The once-daily options are simpler; the diethylpropion immediate-release schedule (three times a day) is more involved.

Both are intended for only a few weeks of use.

Side effects & safety

Because both are stimulants, the common side effects overlap closely: insomnia, dry mouth, restlessness or jitteriness, a faster heartbeat, raised blood pressure, and constipation [1], [2]. Taking the dose early in the day helps with sleep.

Who should not take these (and key cautions)

Both share the same stimulant contraindications.

Avoid either drug if you have heart or blood-vessel disease, uncontrolled high blood pressure, an overactive thyroid, glaucoma, significant agitation or anxiety, or a history of drug abuse; neither should be used within 14 days of an MAOI antidepressant, during pregnancy or breastfeeding, or combined with other appetite suppressants [1], [2].

Both labels also carry warnings about rare but serious primary pulmonary hypertension and valvular heart disease (a concern rooted in the older era of combination "fen-phen" use), and both can cause tolerance and dependence — reasons their use is kept short and supervised [1], [2].

Share your full medical history and medication list with your clinician before starting either.

Cost & availability

Both are inexpensive generics, typically a fraction of the cost of the newer weight-loss medications. Phentermine is widely stocked; diethylpropion is less commonly carried and may need to be sourced from a pharmacy that keeps it.

As Schedule IV controlled substances, both require an in-person or properly supervised prescription and are subject to refill limits.

Longer-term and combination strategies

These older drugs can have a role beyond a single short course — but only as individualized, closely supervised care.

Because two stimulant appetite suppressants stack cardiovascular load, they aren't casually combined; still, experienced clinicians do sometimes use them longer, or pair them with another agent, for selected patients when a single short course isn't enough — much as combination therapy is standard in other chronic conditions — from high blood pressure and diabetes to tuberculosis and cancer.

The same phentermine is FDA-approved for long-term use inside Qsymia (phentermine plus topiramate), which shows the short-term label reflects testing history, not a safety ceiling. Whichever path fits, a supervised program maps it out — with diet and activity habits carrying the result forward — rather than leaving you to regain the weight.

Which is right for you?

• You want the more established short-term option → phentermine is the usual first choice and the most widely used [2].
• Phentermine felt too stimulating → diethylpropion is the common milder alternative in the same class [1].
• You need long-term weight management → neither fits; ask about medications approved for ongoing use instead [3].

Because both are stimulants with real cardiovascular cautions and short approved durations, the right choice depends on your blood pressure, heart history, other medications, and goals — which is exactly what a supervised consultation sorts out.

JumpstartMD physicians prescribe and supervise these older appetite suppressants where appropriate — including longer-term or in combination as part of individualized care — and can also discuss the newer long-term options when those are a better fit.